Clinical Efficacy Evaluation of 1-Year Subcutaneous Immunotherapy for Artemisia sieversiana Pollen Allergic Rhinitis by Serum Metabolomics

Clinical Efficacy Evaluation of 1-Year Subcutaneous Immunotherapy for Artemisia sieversiana Pollen Allergic Rhinitis by Serum Metabolomics

Subcutaneous immunotherapy is the only treatment that improves the natural progression of allergic rhinitis and maintains long-term outcomes after discontinuation of the drug. Metabolomics is increasingly applied in the study of allergic diseases, including allergic rhinitis. However, little is know...

Full description

Bibliographic Details
Main Authors: Hai-Yun Shi, Chen Pan, Ting-Ting Ma, Yan-Lei Chen, Wei-Jun Yan, Jian-Guo Liu, Meng-Da Cao, Hong-Dong Huang, De-Yun Wang, Xue-Yan Wang, Ji-Fu Wei
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-03-01
Series:Frontiers in Pharmacology
Subjects:
subcutaneous immunotherapy
clinical efficacy
seasonal allergic rhinitis
metabolomics
LC-MS
GC-MS
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.00305/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2020.00305/full

Similar Items